Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class ASSE: 603456

"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026

Sep 30, 2026 · Issued by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Notice on Convening the 3rd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A

"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Adjustment of Upper Limit of Repurchase Price Following Implementation of Dividend Distribution for the First Half of 2026Sep 4
"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Using Idle Raised Funds for Cash ManagementAug 19
"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Repurchasing Shares for Cancellation and Reduction of Registered Capital and Notification to CreditorsAug 15
"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Idle Raised FundsAug 14

All Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A news releases